Renal Cell Carcinoma: Future Evolutions in Care
Shared insight on the evolving state of renal cell carcinoma management and hope for future growth in the treatment landscape.
Read More
Selecting Optimal Therapy for Advanced Non-Clear Cell RCC
Focusing their discussion on a real-world patient scenario, expert panelists discuss treatment options in the setting of advanced non-clear cell renal cell carcinoma.
Read More
Relapsed/Refractory Clear Cell RCC: Novel Treatment Strategies
Switching their focus to relapsed/refractory advanced clear cell renal cell carcinoma, key opinion leaders review treatment options in this setting.
Read More
Second-Line Treatment Armamentarium in Clear Cell RCC
Comprehensive insight to treatment options available in the second-line setting of advanced clear cell renal cell carcinoma.
Read More
Rationale Behind Discontinuing IO Therapy in Clear Cell RCC
Focused discussion on the rationale behind discontinuing (or continuing) immunotherapy for patients with advanced clear cell renal cell carcinoma.
Read More
Selecting Therapy for a Real-World Patient With Clear Cell RCC
Centering discussion on a patient scenario of advanced clear cell renal cell carcinoma, panelists reflect on how they would approach selecting first-line therapy.
Read More
Dosing Strategies With First-Line Therapy in Advanced Clear Cell RCC
Panelists consider best practices in dosing while managing patients on first-line therapy for advanced clear cell renal cell carcinoma.
Read More
Advanced Clear Cell RCC: AE Profile of First-Line Combination Therapies
Expert perspectives on the adverse event profiles of first-line combination therapies in the advanced clear cell renal cell carcinoma space.
Read More
Factors in Selecting First-Line Therapy for Patients With Advanced Clear Cell RCC
A brief discussion on the patient and disease characteristics that help to inform selection of best therapy for patients with advanced clear cell renal cell carcinoma.
Read More
Overview of First-Line Combination Therapy in Advanced Clear Cell RCC
Key opinion leaders on renal cell carcinoma management review first-line treatment options in the advanced clear cell disease space.
Read More